Marshall Wace, LLP Inspire Md, Inc. Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Inspire Md, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,860,405 shares of NSPR stock, worth $5.12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,860,405
Previous 1,860,405
-0.0%
Holding current value
$5.12 Million
Previous $4.41 Million
5.49%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding NSPR
# of Institutions
24Shares Held
9.44MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA2.13MShares$5.87 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.03MShares$5.57 Million0.34% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.38MShares$3.79 Million0.35% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA904KShares$2.49 Million5.4% of portfolio
-
Pura Vida Investments, LLC New York, NY451KShares$1.24 Million0.75% of portfolio
About InspireMD, Inc.
- Ticker NSPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,323,200
- Market Cap $22.9M
- Description
- InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applic...